Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     In Vitro Diagnostics     Immunoassay     Chemiluminescence Immunoassays (CLIA)    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

European Chemiluminescence Immunoassays (CLIA) Market

  • Report Code: CH 1003
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

At present, Chemiluminescence immunoassay (CLIA) offers one of the best solutions for the quantification of low concentrations of samples from a complex mixture. The non-radioactive nature of the technique enables it to replace RIA in several immunoassay applications in varied disciplines, including microbiology, agriculture, clinical laboratory, therapeutic medicine, and so on.

 

Geographically, CLIA has a broad market in developed economies of the world like U.S. and Europe as it is a fully automated system that offers highly accurate results.

 

The report “European Chemiluminescence immunoassays (CLIA) Market” analyzes the market by three segments such as instruments, reagents and applications.

 

The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market.

 

The report also provides an extensive competitive landscaping of companies operating in this market. The major vendors in this market are Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), and bioMérieux (France).

 

Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

 

Customization Options:                                                                                           

 

Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:

 

Opportunity Analysis

  • Unmet needs, revenue pockets and potential areas for expansion
  • Comprehensive review of key component providers, assay providers, sole service providers, complete solution providers

 

Current and Emerging Products

  • Analysis of current and emerging  Chemiluminescence immunoassays (CLIA) (FIA)and immunodiagnostic tests
  • Review of current instrumentation technologies

 

Pricing Trends

  • Pricing trend of New high value Immunoassay tests

 

Product Analysis

  • Usage pattern (in-depth trend analysis) of products (Segment wise)
  • Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
  • End-user Adoption rate analysis of the products (Segment wise and Country wise)
  • Comprehensive coverage of Product approvals, Pipeline products and Product recalls

 

Brand/Product Perception Matrix

  • Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
  • Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

 

Alternative Products: Impact analysis

 

MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)



1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
 

2 Executive Summary
 

3 Market Overview
 

4 Chemiluminescence Immunoassays (CLIA)-Europe, By Geographies
4.1 Chemiluminescence Immunoassays (CLIA)-Spain
4.2 Chemiluminescence Immunoassays (CLIA)-United Kingdom
4.3 Chemiluminescence Immunoassays (CLIA)-France
4.4 Chemiluminescence Immunoassays (CLIA)-Germany
4.5 Chemiluminescence Immunoassays (CLIA)-Italy
4.6 Chemiluminescence Immunoassays (CLIA)-Rest of Europe

Please fill in the form below to receive a free copy of the Summary of this Report
















European Chemiluminescence Immunoassays (CLIA) Market

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Europe Immunoassay Europe Immunoassay
Europe holds second largest market position in Global Immunoassay Market. Germany commanded the largest share 20% of the European immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The report “European Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
North America Immunoassay North America Immunoassay
The Americas commanded the largest share 42% of the Global Immunoassay market at an estimated $5248.2 million in 2013 and are expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. The report “North American Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
Asia Immunoassay Asia Immunoassay
Asian immunoassay market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of the Asian immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018. The report “Asian Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539